87786-06-9 Usage
General Description
2-(1-methyl-1H-imidazol-2-yl)-ethylamine, also known as metyrapone, is a synthetic compound used in the treatment of Cushing's syndrome, a disorder caused by high levels of cortisol in the body. It works by inhibiting the production of cortisol, which helps to reduce the symptoms of the condition. Metyrapone is also used in medical research to study the adrenal gland and its function, as well as for diagnostic tests to assess adrenal function. It is usually administered orally or intravenously and has been found to be generally well-tolerated, although it can cause side effects such as dizziness, headache, and gastrointestinal disturbances. Metyrapone is a valuable tool in the management of Cushing's syndrome and continues to be an important drug in clinical and research settings.
Check Digit Verification of cas no
The CAS Registry Mumber 87786-06-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,7,8 and 6 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 87786-06:
(7*8)+(6*7)+(5*7)+(4*8)+(3*6)+(2*0)+(1*6)=189
189 % 10 = 9
So 87786-06-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H11N3/c1-9-5-4-8-6(9)2-3-7/h4-5H,2-3,7H2,1H3
87786-06-9Relevant articles and documents
2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL
-
Paragraph 0618, (2017/07/14)
Compounds of formula (VIII) and compositions for treating disorders related to TRPA1 are described herein.
